Evidence map›Paper›PMID 33717610›Full record

ArticleJournal of pharmaceutical analysis2021

Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion.

Barbara Bojko, Nikita Looby, Mariola Olkowicz, Anna Roszkowska, Bogumiła Kupcewicz, Pedro Reck Dos Santos, Khaled Ramadan, Shaf Keshavjee, Thomas K Waddell, German Gómez-Ríos and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Perspective onJournal of pharmaceutical analysis · 2024
    Article
  5. Emerging contaminants: A One Health perspective.Innovation (Cambridge (Mass.)) · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. ACS environmental Au · 2022
    Review
  17. Article
  18. Article
  19. Dynamic Metabolic Changes During ProlongedFrontiers in immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Barbara BojkoDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Nikita LoobyDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Mariola OlkowiczDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Anna RoszkowskaDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Bogumiła KupcewiczDepartment of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-089, Bydgoszcz, Poland.
Pedro Reck Dos SantosUniversity Health Network - TGH, Toronto, ON M5G 2C4, Canada.
Khaled RamadanUniversity Health Network - TGH, Toronto, ON M5G 2C4, Canada.
Shaf KeshavjeeUniversity Health Network - TGH, Toronto, ON M5G 2C4, Canada.
Thomas K WaddellUniversity Health Network - TGH, Toronto, ON M5G 2C4, Canada.
German Gómez-RíosDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Marcos TasconDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Krzysztof GoryńskiDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
Marcelo CypelUniversity Health Network - TGH, Toronto, ON M5G 2C4, Canada.
Janusz PawliszynDepartment of Chemistry, University of Waterloo, Waterloo, ON M1B 6G3, Canada.
University of Waterloo · CAUniversity Health Network · CAJagiellonian University · PLNicolaus Copernicus University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of a novel in vivo lung perfusion (IVLP) procedure allows localized delivery of high-dose doxorubicin (DOX) for targeting residual micrometastatic disease in the lungs. However, DOX delivery via IVLP requires careful monitoring of drug level to ensure tissue concentrations of this agent remain in the therapeutic window. A small dimension nitinol wire coated with a sorbent of biocompatible morphology (Bio-SPME) has been clinically evaluated for in vivo lung tissue extraction and determination of DOX and its key metabolites. The in vivo Bio-SPME-IVLP experiments were performed on pig model over various (150 and 225 mg/m

Indexed as

In vivo solid phase microextractionMetabolite profilingSpatial resolutionTherapeutic drug monitoringTissue analysis

Identifiers

PMID33717610
PMCPMC7930785
OpenAlexW3081919330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.